Apply for product authorisation by the deadlines to keep your products on the NI market
The following EU BPR active substance approval dates are coming up:
- Reaction mass of peracetic acid and peroxyoctanoic acid (CAS 79-21-0 and 33734-57-5 EC 201-186-8 and 450-280-7) in product types 2, 3 and 4
1 April 2022
- Active chlorine generated from sodium chloride by electrolysis (CAS n/a EC n/a) in product types 2, 3, 4 and 5
1 July 2022
- Active chlorine released from hypochlorous acid (CAS 7790-92-3 EC 232-232-5) in product types 2, 3, 4 and 5
1 July 2022
If you supply biocidal products containing these active substances in the relevant product types, don’t forget to apply for EU BPR product authorisation by the dates above to keep them on the NI market.
Submit a notification by the deadline to keep active substances in the EU Review Programme
The European Chemicals Agency (ECHA) has published open invitations to provide an opportunity for a person, company or task force/consortium to notify an intention to take up or take over the role of participant in the EU Review Programme for the following active substance/product type combinations. This affects NI.
Anyone wishing to support one of the active substance/product type combinations listed below in the EU will need to submit a notification to ECHA by the following deadlines:
- 7a-ethyldihydro-1H,3H,5H-oxazolo[3,4-c]oxazole (EDHO) (CAS 7747-35-5 EC 231-810-4) in product types 6 and 13
6 July 2022
- cis-1-(3-chloroallyl)-3,5,7-triaza-1-azoniaadamantane chloride (cis CTAC) (CAS 51229-78-8 EC 426-020-3) in product types 6 and 13
6 July 2022
- Methenamine 3-chloroallylochloride (CTAC) (CAS 4080-31-3 EC 223-805-0) in product types 6, 12 and 13
6 July 2022
If a notification to take over the role of participant is not received, these active substance/product type combinations will be subject to an EU non-approval decision.
Biocidal products containing active substances with EU non-approval decisions for the relevant product types will have to be removed from the NI market. HSE will provide separate updates on these where relevant.
If you are aware of any disproportionate negative effects that are likely to arise from the non-approval of any of the active substance/product type combinations listed above, please contact us.
Active substance expiry date postponed whilst the renewal evaluation is completed in the EU
For reasons beyond the control of the applicant, the approval of the active substance/product type combination listed below was likely to expire before a decision could be taken on its renewal under the EU BPR.
To allow sufficient time for the renewal evaluation to be completed, a decision has been taken to postpone the expiry of the approval until the following date. This affects NI:
If you want to supply new biocidal products containing this active substance, you can still apply for EU BPR product authorisation.
New products (including new trade names) must not be supplied in NI until product authorisation is granted.
HSE will provide a separate update on the renewal decision when relevant.
|
